Reclast News
Most Popular Reclast Story
FDA calls 'all clear' on bone meds
Bone drugs Reclast and Fosamax can step out from under a safety cloud, because the FDA came, saw and found nothing. The agency had been reviewing the two meds--sold by Novartis and Merck,... Read more...
Latest Headlines
- November 13, 2008
- June 5, 2008
- January 8, 2008
- October 5, 2007
- September 18, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
